🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Prevention of Rejection in Kidney Transplant

REgulatory T Cell Therapy to Achieve Immunosuppression REduction NCT06552169Phase 27 sites📍 Phoenix📍 Chicago📍 Rochester Singulera Therapeutics Inc. · Tests: Arm 1: SOC (mTOR + CNI), Arm 2A: TRACT/MONO mTOR, Arm 2B: TRACT/MONO CNI CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk NCT07053462Phase 1, Phase 21 site📍 Beijing AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC · Tests: Ex Vivo CRISPR-Cas9 Gene Editing of Donor Kidney, Kidney Transplantation with Standard Care VEL-101 to Prevent Rejection After Kidney Transplantation NCT07290777Phase 21 site📍 Dallas Veloxis Pharmaceuticals · Tests: Tacrolimus (TAC), VEL-101 Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant NCT05027906Phase 1, Phase 29 sites📍 Cincinnati📍 Camperdown📍 Adelaide Eledon Pharmaceuticals · Tests: AT-1501
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy